De novo maintenance therapy with denileukin diftitox (Ontak®) in a patient with peripheral T‐cell lymphoma is associated with prolonged remission

1969 Cancer Facts and Figures

1968 • 8,880 citations

Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

2001 • 612 citations

FOXP3 modifies the phenotypic and functional properties of regulatory T cells

2007 • 262 citations

Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma

2005 • 227 citations

Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas

2001 • 160 citations

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

2004 • 143 citations

Phase II trial of denileukin diftitox for relapsed/refractory T‐cell non‐Hodgkin lymphoma

2006 • 135 citations

Phase II Study of Denileukin Diftitox for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

2004 • 96 citations

A Mini Meta‐Analysis of Studies on CD4⁺CD25⁺ T cells in Human Type 1 Diabetes

2006 • 77 citations

Histology Impacts the Outcome of Peripheral T-Cell Lymphomas after High Dose Chemotherapy and Stem Cell Transplant

2004 • 70 citations

A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.

2003 • 70 citations

All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

2004 • 66 citations

High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma

2004 • 46 citations

Denileukin Diftitox as Novel Targeted Therapy for Lymphoid Malignancies

2007 • 34 citations

Peripheral T- cell lymphomas: diagnosis and management

2003 • 30 citations